News | April 7, 2020
It’s Rosacea Awareness Month, and the National Rosacea Society (NRS) continues to educate the public on this potentially serious condition estimated to affect more than 16 million Americans. “Although the occurrence of...
News | October 18, 2019
Results from nine clinical trials of Foamix Pharmaceutical investigational products will be presented in five posters at the 39th Annual Fall Clinical Dermatology Conferencein Las Vegas. Findings relate FMX101 for the treatment of...
News | June 26, 2019
Results of the phase 3b/4 ANSWER study, recently published onlinein the Journal of the American Academy of Dermatology, show that concomitant use of Oracea Capsules and Soolantra Cream provided significant improvement in...
Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposium
Foamix Submits NDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
DermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap